Heon Jong Yoo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Heon Jong Yoo has a total of 242 co-authors. Here are the top co-authors by number of shared publications:
- Myong Cheol Lim
Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea
17 shared publications - Byung Hun Kang
Department of Obstetrics & Gynecology, Chungnam National University School of Medicine, 266 Munhwa-ro, Jung-gu, Daejeon 35015, Republic of Korea
12 shared publications Sang-Yoon Park
11 shared publications- Sokbom Kang
Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea
11 shared publications Soo Youn Song
Chungnam Natl Univ, Sejong Hosp, Dept Obstet & Gynecol, Sejong, South Korea
10 shared publicationsKi Hwan Lee
9 shared publications
Latest Publications
- Open Access
- 18 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (14) , 5642
Impact of Contrast-Enhanced Computed Tomography on the Management of Postpartum Hemorrhage with Extravasation
Background: This study aimed to investigate the association of contrast extravasation (EV) detected on contrast-enhanced computed tomography (CE-CT) with the clinical characteristics, management, and outcomes of patients with postpartum hemorrhage (PPH). Methods: We retrospectively analyzed 51 patients with PPH who underwent CE-CT between August 2013 and July 2024. Patients were classified into EV (−) group (n = 28) and EV (+) group (n = 23). Baseline characteristics, management strategies, and clinical outcomes were compared. Results: The proportion of patients with a shock index (SI) ≥ 1.0 was significantly higher in the EV (+) group (10.7% vs. 39.1%, p = 0.017). Surgical intervention was more frequently required in the EV (+) group (10.7% vs. 56.5%, p = 0.001), whereas conservative management alone was more frequently successful in the EV (−) group (89.3% vs. 43.5%, p = 0.001). The EV (+) group showed higher rates of massive blood loss (> 2000 mL, 3.6% vs. 34.8%, p = 0.009), longer hospital stays (4.61 ± 2.61 vs. 6.88 ± 3.78 days, p = 0.034), and more frequent intensive care unit (ICU) admission (10.7% vs. 34.8%, p = 0.039). Patients in the EV (+) group had higher transfusion requirements (p < 0.005) and increased rates of disseminated intravascular coagulation (7.1% vs. 30.4%, p = 0.032). Conclusions: The presence of EV on CE-CT in PPH was associated with more severe clinical features, including greater transfusion requirements, increased rates of surgical intervention, ICU admission, and disseminated intravascular coagulation (DIC). Additionally, a higher proportion of patients with EV had a shock index ≥ 1.0, indicating early hemodynamic compromise.
- 18 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (14) , 5642
Open AccessImpact of Contrast-Enhanced Computed Tomography on the Management of Postpartum Hemorrhage with Extravasation
Background: This study aimed to investigate the association of contrast extravasation (EV) detected on contrast-enhanced computed tomography (CE-CT) with the clinical characteristics, management, and outcomes of patients with postpartum hemorrhage (PPH). Methods: We retrospectively analyzed 51 patients with PPH who underwent CE-CT between August 2013 and July 2024. Patients were classified into EV (−) group (n = 28) and EV (+) group (n = 23). Baseline characteristics, management strategies, and clinical outcomes were compared. Results: The proportion of patients with a shock index (SI) ≥ 1.0 was significantly higher in the EV (+) group (10.7% vs. 39.1%, p = 0.017). Surgical intervention was more frequently required in the EV (+) group (10.7% vs. 56.5%, p = 0.001), whereas conservative management alone was more frequently successful in the EV (−) group (89.3% vs. 43.5%, p = 0.001). The EV (+) group showed higher rates of massive blood loss (> 2000 mL, 3.6% vs. 34.8%, p = 0.009), longer hospital stays (4.61 ± 2.61 vs. 6.88 ± 3.78 days, p = 0.034), and more frequent intensive care unit (ICU) admission (10.7% vs. 34.8%, p = 0.039). Patients in the EV (+) group had higher transfusion requirements (p < 0.005) and increased rates of disseminated intravascular coagulation (7.1% vs. 30.4%, p = 0.032). Conclusions: The presence of EV on CE-CT in PPH was associated with more severe clinical features, including greater transfusion requirements, increased rates of surgical intervention, ICU admission, and disseminated intravascular coagulation (DIC). Additionally, a higher proportion of patients with EV had a shock index ≥ 1.0, indicating early hemodynamic compromise.
- Open Access
- 1 January 2026
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 37 (3)
Pattern of first recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy
Kim JH, et al. J Gynecol Oncol. 2025 Nov;37:e52. https://doi.org/10.3802/jgo.2026.37.e52
- 1 January 2026
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 37 (3)
Open AccessPattern of first recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy
Kim JH, et al. J Gynecol Oncol. 2025 Nov;37:e52. https://doi.org/10.3802/jgo.2026.37.e52
- Open Access
- 26 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (3) , 799
Comparison of Surgical Outcomes Between Single-Port Access Laparoscopic and Single-Site Robotic Surgery in Benign Gynecologic Diseases: A Single-Center Cohort Study
Background/Objectives: To compare the outcomes of single-port access laparoscopic surgery (SPALS) and single-site robotic surgery (SSRS) for benign gynecological diseases, we retrospectively analyzed clinical data from 367 patients who underwent gynecologic surgery at Sejong Chungnam National University Hospital from October 2020 to December 2023. Methods: Of these 367 patients, 197 underwent SPALS, whereas 170 underwent SSRS. The SPALS group comprised 87 patients who underwent hysterectomy; 107, adnexal surgery (cystectomy: 44, adnexectomy: 63); and 1 myomectomy. The SSRS group included 68 patients who underwent myomectomy; 61, adnexal surgery (cystectomy: 52, adnexectomy: 9); 35, hysterectomy, and 4, sacrocolpopexy. Results: Both surgical techniques were successful, with no patients requiring open surgery. No significant differences were observed in the baseline characteristics between the two groups. Compared with the SPALS group, the SSRS group had a younger age (39.8 ± 9.5 vs. 44.5 ± 12.3 years, p = 0.001). Severe intra-abdominal adhesions were more frequently observed in the SSRS group (p = 0.004). Operation time (118.1 ± 65.9 vs. 57.1 ± 27.3 min, p = 0.001), gas passing time (39.4 ± 15.37 vs. 30.4 ± 13.5 h, p = 0.001), and hospital length of stay (4.26 ± 1.02 vs. 4.02 ± 0.8 days, p = 0.012) were significantly longer in the SSRS group. However, no significant differences were found between the two groups in terms of intraoperative blood loss, intraoperative complications, or readmission rates. Conclusions: SSRS offers a feasible and promising approach for treating gynecological benign diseases. Younger and lower-parity patients tend to undergo SSRS rather than SPALS, with SSRS primarily performed for myomectomy and complex adnexal surgery. However, operation time and gas passing time were significantly longer in the SSRS group.
- 26 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (3) , 799
Open AccessComparison of Surgical Outcomes Between Single-Port Access Laparoscopic and Single-Site Robotic Surgery in Benign Gynecologic Diseases: A Single-Center Cohort Study
Background/Objectives: To compare the outcomes of single-port access laparoscopic surgery (SPALS) and single-site robotic surgery (SSRS) for benign gynecological diseases, we retrospectively analyzed clinical data from 367 patients who underwent gynecologic surgery at Sejong Chungnam National University Hospital from October 2020 to December 2023. Methods: Of these 367 patients, 197 underwent SPALS, whereas 170 underwent SSRS. The SPALS group comprised 87 patients who underwent hysterectomy; 107, adnexal surgery (cystectomy: 44, adnexectomy: 63); and 1 myomectomy. The SSRS group included 68 patients who underwent myomectomy; 61, adnexal surgery (cystectomy: 52, adnexectomy: 9); 35, hysterectomy, and 4, sacrocolpopexy. Results: Both surgical techniques were successful, with no patients requiring open surgery. No significant differences were observed in the baseline characteristics between the two groups. Compared with the SPALS group, the SSRS group had a younger age (39.8 ± 9.5 vs. 44.5 ± 12.3 years, p = 0.001). Severe intra-abdominal adhesions were more frequently observed in the SSRS group (p = 0.004). Operation time (118.1 ± 65.9 vs. 57.1 ± 27.3 min, p = 0.001), gas passing time (39.4 ± 15.37 vs. 30.4 ± 13.5 h, p = 0.001), and hospital length of stay (4.26 ± 1.02 vs. 4.02 ± 0.8 days, p = 0.012) were significantly longer in the SSRS group. However, no significant differences were found between the two groups in terms of intraoperative blood loss, intraoperative complications, or readmission rates. Conclusions: SSRS offers a feasible and promising approach for treating gynecological benign diseases. Younger and lower-parity patients tend to undergo SSRS rather than SPALS, with SSRS primarily performed for myomectomy and complex adnexal surgery. However, operation time and gas passing time were significantly longer in the SSRS group.
- Open Access
- 2 January 2025
- Published by MDPI AG in Preprints.org
Comparison of Surgical Outcomes Between Single-Port Assess Laparoscopic and Single-Site Robotic Surgery in Benign Gynecologic Diseases: A Single-Center Cohort Study
Background/Objectives: To compare the outcomes of single-port assessment laparoscopic surgery (SPALS) and single-site robotic surgery (SSRS) for benign gynecological diseases. Methods: The clinical data of 367 patients who underwent gynecologic surgery at Sejong Chungnam National University Hospital from October 2020 to December 2023 were analyzed retrospectively. Of these 367 patients, 197 received SPALS while 170 underwent SSRS. The SPALS group comprise 87 hysterectomies, 107 adnexal surgeries (44 cystectomies, 63 adnexectomies) and 1 myomectomy. The SSRS group includes 68 myomectomies, 61 adnexal surgeries (52 cystectomies, 9 adnexectomies), 35 hysterectomies, and 4 sacrocolpopexies. Results: The results showed that both surgical techniques were successful, and no patients underwent open surgery. There were no significant differences in the baseline characteristics between the two groups. Compared with the SPALS group, the SSRS group had younger age (39.8±9.5 vs 44.5±12.3 years, p = 0.001). Severe intra-abdominal adhesions were more frequently observed in the SSRS group (p = 0.004). Operation time (118.1±65.9 vs 57.1±27.3 min, p = 0.001) and gas passing time (39.4±15.37 vs 30.4±13.5 hours, p = 0.001) were found to be longer, along with more hospital days (4.26±1.02 vs 4.02±0.8 days, p = 0.012), in SSRS group. However, there were no significant differences between the two groups in terms of intraoperative blood loss, intraoperative complications, or readmission rates. Conclusions: SSRS offers a feasible and promising approach for treating gynecological benign diseases. Younger and lower parity patients tend to have SSRS, compare to SPALS, and SSRS was mainly used for myomectomy and complex adnexal surgery. However, operation time and gas passing time were found to be longer in SSRS group.
- 2 January 2025
- Published by MDPI AG in Preprints.org
Open AccessComparison of Surgical Outcomes Between Single-Port Assess Laparoscopic and Single-Site Robotic Surgery in Benign Gynecologic Diseases: A Single-Center Cohort Study
Background/Objectives: To compare the outcomes of single-port assessment laparoscopic surgery (SPALS) and single-site robotic surgery (SSRS) for benign gynecological diseases. Methods: The clinical data of 367 patients who underwent gynecologic surgery at Sejong Chungnam National University Hospital from October 2020 to December 2023 were analyzed retrospectively. Of these 367 patients, 197 received SPALS while 170 underwent SSRS. The SPALS group comprise 87 hysterectomies, 107 adnexal surgeries (44 cystectomies, 63 adnexectomies) and 1 myomectomy. The SSRS group includes 68 myomectomies, 61 adnexal surgeries (52 cystectomies, 9 adnexectomies), 35 hysterectomies, and 4 sacrocolpopexies. Results: The results showed that both surgical techniques were successful, and no patients underwent open surgery. There were no significant differences in the baseline characteristics between the two groups. Compared with the SPALS group, the SSRS group had younger age (39.8±9.5 vs 44.5±12.3 years, p = 0.001). Severe intra-abdominal adhesions were more frequently observed in the SSRS group (p = 0.004). Operation time (118.1±65.9 vs 57.1±27.3 min, p = 0.001) and gas passing time (39.4±15.37 vs 30.4±13.5 hours, p = 0.001) were found to be longer, along with more hospital days (4.26±1.02 vs 4.02±0.8 days, p = 0.012), in SSRS group. However, there were no significant differences between the two groups in terms of intraoperative blood loss, intraoperative complications, or readmission rates. Conclusions: SSRS offers a feasible and promising approach for treating gynecological benign diseases. Younger and lower parity patients tend to have SSRS, compare to SPALS, and SSRS was mainly used for myomectomy and complex adnexal surgery. However, operation time and gas passing time were found to be longer in SSRS group.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 36 (6)
Developing standardized informed consent for hysterectomy and vulva cancer surgery
Oh S, et al. J Gynecol Oncol. 2025 Apr;36:e107. https://doi.org/10.3802/jgo.2025.36.e107
- 1 January 2025
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 36 (6)
Open AccessDeveloping standardized informed consent for hysterectomy and vulva cancer surgery
Oh S, et al. J Gynecol Oncol. 2025 Apr;36:e107. https://doi.org/10.3802/jgo.2025.36.e107
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 36 (3)
Current peritonectomy practice during debulking surgery in patients with newly diagnosed advanced ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 4004)
Kim MS, et al. J Gynecol Oncol. 2024 Oct;36:e39. https://doi.org/10.3802/jgo.2025.36.e39
- 1 January 2025
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 36 (3)
Open AccessCurrent peritonectomy practice during debulking surgery in patients with newly diagnosed advanced ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 4004)
Kim MS, et al. J Gynecol Oncol. 2024 Oct;36:e39. https://doi.org/10.3802/jgo.2025.36.e39
- Open Access
- 22 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (47) , e40487
Predictive impact of clinical factors on chemosensitivity in advanced high-grade serous ovarian carcinoma according to chemotherapy response score
The use of neoadjuvant chemotherapy (NAC) as a first-line therapy for advanced high-grade serous ovarian carcinoma (HGSOC) has increased. However, several studies have reported NAC-induced platinum resistance. This study aimed to evaluate the predictive impact of clinical factors on chemotherapy response score (CRS) and to select patients who would respond well to NAC. This multicenter retrospective (study included patients treated between January 2016 and December 2021). International Federation of Gynecology and Obstetrics stage IIIC and IV HGSOC patients were eligible. Institutionally strict complete resectability criteria were used in the present study. Pathological slides were scored according to the CRS criteria. Among 172 patients with HGSOC, 87 (50.6%) had stage IIIC disease and 85 (49.4%) had stage IV disease. And 35 (20.4%) had CRS1, 103 patients were CRS2 (59.9%), and 34 patients were CRS3 (19.7%). Compared with CRS1, simultaneous metastases to distant lymph nodes and solid organs confirmed by imaging were associated with a 75% reduction in CRS2 (odds ratio = 0.25; 95% confidence interval: 0.09–0.70; P = .008). And breast cancer susceptibility gene 1/2 mutation was positively (odds ratio = 8.41; 95% confidence interval: 2.25–31.52; P = .002) associated with CRS3 compared to CRS1. Patients with CRS3 had significantly longer progression-free survival (PFS), with median PFS of 9.8, 14.8, and 27.0 months for CRS of 1, 2, and 3, respectively (P < .001). Overall survival was also prolonged in patients with CRS3 (P < .001). Germline breast cancer susceptibility gene 1/2 mutation was a predictor of CRS3 and a good prognostic factor for the survival rate. Simultaneous metastasis to distant lymph nodes and solid organs is a predictor of CRS1. CRS inversely correlated with PFS and overall survival.
- 22 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (47) , e40487
Open AccessPredictive impact of clinical factors on chemosensitivity in advanced high-grade serous ovarian carcinoma according to chemotherapy response score
The use of neoadjuvant chemotherapy (NAC) as a first-line therapy for advanced high-grade serous ovarian carcinoma (HGSOC) has increased. However, several studies have reported NAC-induced platinum resistance. This study aimed to evaluate the predictive impact of clinical factors on chemotherapy response score (CRS) and to select patients who would respond well to NAC. This multicenter retrospective (study included patients treated between January 2016 and December 2021). International Federation of Gynecology and Obstetrics stage IIIC and IV HGSOC patients were eligible. Institutionally strict complete resectability criteria were used in the present study. Pathological slides were scored according to the CRS criteria. Among 172 patients with HGSOC, 87 (50.6%) had stage IIIC disease and 85 (49.4%) had stage IV disease. And 35 (20.4%) had CRS1, 103 patients were CRS2 (59.9%), and 34 patients were CRS3 (19.7%). Compared with CRS1, simultaneous metastases to distant lymph nodes and solid organs confirmed by imaging were associated with a 75% reduction in CRS2 (odds ratio = 0.25; 95% confidence interval: 0.09–0.70; P = .008). And breast cancer susceptibility gene 1/2 mutation was positively (odds ratio = 8.41; 95% confidence interval: 2.25–31.52; P = .002) associated with CRS3 compared to CRS1. Patients with CRS3 had significantly longer progression-free survival (PFS), with median PFS of 9.8, 14.8, and 27.0 months for CRS of 1, 2, and 3, respectively (P < .001). Overall survival was also prolonged in patients with CRS3 (P < .001). Germline breast cancer susceptibility gene 1/2 mutation was a predictor of CRS3 and a good prognostic factor for the survival rate. Simultaneous metastasis to distant lymph nodes and solid organs is a predictor of CRS1. CRS inversely correlated with PFS and overall survival.
- Open Access
- 1 August 2024
- Published by Springer Nature in World Journal of Emergency Surgery
- Vol. 19 (1) , 27
Outcomes and prognosis of postpartum hemorrhage according to management protocol: an 11-year retrospective study from two referral centers
Background: No standard treatment guidelines have been established for postpartum hemorrhage (PPH). We aimed to assess the differences in outcomes and prognoses between patients with PPH who underwent surgical and non-surgical treatment. Methods: This retrospective study included 230 patients diagnosed with PPH at two referral hospitals between August 2013 and October 2023. The patients were divided into non-surgical (group 1, n = 159) and surgical intervention groups (group 2, n = 71). A subgroup analysis was performed by dividing the surgical intervention group into immediate (n = 45) and delayed surgical intervention groups (n = 26). Results: Initial lactic acid levels and shock index were significantly higher in group 2 (2.85 ± 1.37 vs. 4.54 ± 3.63 mmol/L, p = 0.001, and 0.83 ± 0.26 vs. 1.10 ± 0.51, p < 0.001, respectively). Conversely, initial heart rate and body temperature were significantly lower in group 2 (92.5 ± 21.0 vs. 109.0 ± 28.1 beat/min, p < 0.001, and 37.3 ± 0.8 °C vs. 37.0 ± 0.9 °C, p = 0.011, respectively). Logistic regression analysis identified low initial body temperature, high lactic acid level, and shock index as independent predictors of surgical intervention (p = 0.029, p = 0.027, and p = 0.049, respectively). Regarding the causes of PPH, tone was significantly more prevalent in group 1 (57.2% vs. 35.2%, p = 0.002), whereas trauma was significantly more prevalent in group 2 (24.5% vs. 39.4%, p = 0.030). Group 2 had worse overall outcomes and prognoses than group 1. The subgroup analysis showed significantly higher rates of uterine atony combined with other causes, hysterectomy, and disseminated intravascular coagulopathy in the delayed surgical intervention group than the immediate surgical intervention group (42.2% vs. 69.2%, p = 0.027; 51.1% vs. 73.1%, p = 0.049; and 17.8% vs. 46.2%, p = 0.018, respectively). Conclusions: Patients with PPH presenting with increased lactic acid levels and shock index and decreased body temperature may be surgical candidates. Additionally, immediate surgical intervention in patients with uterine atony combined with other causes of PPH could improve prognosis and reduce postoperative complications.
- 1 August 2024
- Published by Springer Nature in World Journal of Emergency Surgery
- Vol. 19 (1) , 27
Open AccessOutcomes and prognosis of postpartum hemorrhage according to management protocol: an 11-year retrospective study from two referral centers
Background: No standard treatment guidelines have been established for postpartum hemorrhage (PPH). We aimed to assess the differences in outcomes and prognoses between patients with PPH who underwent surgical and non-surgical treatment. Methods: This retrospective study included 230 patients diagnosed with PPH at two referral hospitals between August 2013 and October 2023. The patients were divided into non-surgical (group 1, n = 159) and surgical intervention groups (group 2, n = 71). A subgroup analysis was performed by dividing the surgical intervention group into immediate (n = 45) and delayed surgical intervention groups (n = 26). Results: Initial lactic acid levels and shock index were significantly higher in group 2 (2.85 ± 1.37 vs. 4.54 ± 3.63 mmol/L, p = 0.001, and 0.83 ± 0.26 vs. 1.10 ± 0.51, p < 0.001, respectively). Conversely, initial heart rate and body temperature were significantly lower in group 2 (92.5 ± 21.0 vs. 109.0 ± 28.1 beat/min, p < 0.001, and 37.3 ± 0.8 °C vs. 37.0 ± 0.9 °C, p = 0.011, respectively). Logistic regression analysis identified low initial body temperature, high lactic acid level, and shock index as independent predictors of surgical intervention (p = 0.029, p = 0.027, and p = 0.049, respectively). Regarding the causes of PPH, tone was significantly more prevalent in group 1 (57.2% vs. 35.2%, p = 0.002), whereas trauma was significantly more prevalent in group 2 (24.5% vs. 39.4%, p = 0.030). Group 2 had worse overall outcomes and prognoses than group 1. The subgroup analysis showed significantly higher rates of uterine atony combined with other causes, hysterectomy, and disseminated intravascular coagulopathy in the delayed surgical intervention group than the immediate surgical intervention group (42.2% vs. 69.2%, p = 0.027; 51.1% vs. 73.1%, p = 0.049; and 17.8% vs. 46.2%, p = 0.018, respectively). Conclusions: Patients with PPH presenting with increased lactic acid levels and shock index and decreased body temperature may be surgical candidates. Additionally, immediate surgical intervention in patients with uterine atony combined with other causes of PPH could improve prognosis and reduce postoperative complications.
- Open Access
- 2 February 2024
- Published by MDPI AG in Preprints.org
The Synergistic Effect of APE1/Ref-1 and Aspirin Enhances PEO14 Ovarian Cancer Cell Apoptosis via Parp Cleavage
Ovarian cancer poses a significant therapeutic challenge owing to the lack of specific targets for treatment. New treatment strategies are needed to improve patient outcomes and reduce the toxicity of existing therapies. This study aimed to investigate the synergistic effects of recombi-nant human apurinic/apyrimidinic endonuclease 1/redox factor 1 (rhAPE1/Ref-1) and aspirin on PEO14 and CAOV-3 ovarian cancer cells and human umbilical vein endothelial cells (HUVECs). Specifically, this study examined the mechanisms underlying the effect of rhAPE1/Ref-1 and as-pirin on cell death and the associated pathways. Cell viability was assessed using the MTT assay, and flow cytometry analysis and caspase-3/7 activity assays were conducted to determine apop-tosis. Western blotting was performed to evaluate the cleavage of poly(ADP-ribose) polymerase (PARP). Exposure to aspirin (3 mM) for 24 h did not affect cell viability in PEO14. Co-incubation of aspirin with rhAPE1/Ref-1 in PEO14 cells led to rhAPE1/Ref-1 acetylation and intracellular hyperacetylation. Co-treatment with aspirin (3 mM) and rhAPE1/Ref-1 induced a rhAPE1/Ref-1 concentration-dependent increase in cell death, particularly in PEO14 cells, as well as apoptosis, caspase-3/7 activation, and PARP cleavage. Furthermore, this combination treatment significantly increased paclitaxel-induced PEO14 cell death. Therefore, co-administration with rhAPE1/Ref-1 and aspirin is a potential strategy for ovarian cancer treatment.
- 2 February 2024
- Published by MDPI AG in Preprints.org
Open AccessThe Synergistic Effect of APE1/Ref-1 and Aspirin Enhances PEO14 Ovarian Cancer Cell Apoptosis via Parp Cleavage
Ovarian cancer poses a significant therapeutic challenge owing to the lack of specific targets for treatment. New treatment strategies are needed to improve patient outcomes and reduce the toxicity of existing therapies. This study aimed to investigate the synergistic effects of recombi-nant human apurinic/apyrimidinic endonuclease 1/redox factor 1 (rhAPE1/Ref-1) and aspirin on PEO14 and CAOV-3 ovarian cancer cells and human umbilical vein endothelial cells (HUVECs). Specifically, this study examined the mechanisms underlying the effect of rhAPE1/Ref-1 and as-pirin on cell death and the associated pathways. Cell viability was assessed using the MTT assay, and flow cytometry analysis and caspase-3/7 activity assays were conducted to determine apop-tosis. Western blotting was performed to evaluate the cleavage of poly(ADP-ribose) polymerase (PARP). Exposure to aspirin (3 mM) for 24 h did not affect cell viability in PEO14. Co-incubation of aspirin with rhAPE1/Ref-1 in PEO14 cells led to rhAPE1/Ref-1 acetylation and intracellular hyperacetylation. Co-treatment with aspirin (3 mM) and rhAPE1/Ref-1 induced a rhAPE1/Ref-1 concentration-dependent increase in cell death, particularly in PEO14 cells, as well as apoptosis, caspase-3/7 activation, and PARP cleavage. Furthermore, this combination treatment significantly increased paclitaxel-induced PEO14 cell death. Therefore, co-administration with rhAPE1/Ref-1 and aspirin is a potential strategy for ovarian cancer treatment.
- Top Cited PapersOpen Access
- 23 October 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (10) , 2868
Endometriosis-Related Chronic Pelvic Pain
Endometriosis, which is the presence of endometrial stroma and glands outside the uterus, is one of the most frequently diagnosed gynecologic diseases in reproductive women. Patients with endometriosis suffer from various pain symptoms such as dysmenorrhea, dyspareunia, and chronic pelvic pain. The pathophysiology for chronic pain in patients with endometriosis has not been fully understood. Altered inflammatory responses have been shown to contribute to pain symptoms. Increased secretion of cytokines, angiogenic factors, and nerve growth factors has been suggested to increase pain. Also, altered distribution of nerve fibers may also contribute to chronic pain. Aside from local contributing factors, sensitization of the nervous system is also important in understanding persistent pain in endometriosis. Peripheral sensitization as well as central sensitization have been identified in patients with endometriosis. These sensitizations of the nervous system can also explain increased incidence of comorbidities related to pain such as irritable bowel disease, bladder pain syndrome, and vulvodynia in patients with endometriosis. In conclusion, there are various possible mechanisms behind pain in patients with endometriosis, and understanding these mechanisms can help clinicians understand the nature of the pain symptoms and decide on treatments for endometriosis-related pain symptoms.
- 23 October 2023
- Published by MDPI AG in Biomedicines
- Vol. 11 (10) , 2868
Top Cited PapersOpen AccessEndometriosis-Related Chronic Pelvic Pain
Endometriosis, which is the presence of endometrial stroma and glands outside the uterus, is one of the most frequently diagnosed gynecologic diseases in reproductive women. Patients with endometriosis suffer from various pain symptoms such as dysmenorrhea, dyspareunia, and chronic pelvic pain. The pathophysiology for chronic pain in patients with endometriosis has not been fully understood. Altered inflammatory responses have been shown to contribute to pain symptoms. Increased secretion of cytokines, angiogenic factors, and nerve growth factors has been suggested to increase pain. Also, altered distribution of nerve fibers may also contribute to chronic pain. Aside from local contributing factors, sensitization of the nervous system is also important in understanding persistent pain in endometriosis. Peripheral sensitization as well as central sensitization have been identified in patients with endometriosis. These sensitizations of the nervous system can also explain increased incidence of comorbidities related to pain such as irritable bowel disease, bladder pain syndrome, and vulvodynia in patients with endometriosis. In conclusion, there are various possible mechanisms behind pain in patients with endometriosis, and understanding these mechanisms can help clinicians understand the nature of the pain symptoms and decide on treatments for endometriosis-related pain symptoms.